Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3998-90-1 | MDL No. : | MFCD04038391 |
Formula : | C8H8ClNO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | BDWMGYZSQKGUFA-UHFFFAOYSA-N |
M.W : | 185.61 | Pubchem ID : | 2759833 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.25 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 45.49 |
TPSA : | 39.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.96 cm/s |
Log Po/w (iLOGP) : | 2.21 |
Log Po/w (XLOGP3) : | 2.07 |
Log Po/w (WLOGP) : | 1.83 |
Log Po/w (MLOGP) : | 1.25 |
Log Po/w (SILICOS-IT) : | 2.29 |
Consensus Log Po/w : | 1.93 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.53 |
Solubility : | 0.544 mg/ml ; 0.00293 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.52 |
Solubility : | 0.558 mg/ml ; 0.003 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.1 |
Solubility : | 0.146 mg/ml ; 0.000785 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.83 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302+H312+H332-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | With palladium 10% on activated carbon; hydrogen; triethylamine In N,N-dimethyl-formamide at 20℃; for 15 h; | Methyl 2-chloro-6-methylpyridin-4-carboxylate (15.0 g, 80.8 mmol), 10percent palladium carbon powder (50percent water containing product) (5.00 g), and triethylamine (22.5 mL, 162 mmol) were stirred in N,N-dimethylformamide (200 mL) under hydrogen atmosphere, at room temperature, for 15 h. The mixture was filtered, and the solvent was removed by evaporation under reduced pressure. The residue was purified by silica gel chromatography (ethyl acetate: methanol= 100:0-50:1) to give the title compound (14.8 g, 61percent) as an oil. 1H NMR (CDCl3) d: 2.64 (3H, s), 3.95 (3H, s), 7.64 (1H, dd, J =5.2, 0.8 Hz), 7.72 (1H, s), 8.65 (1H, d, J = 4.7 Hz). |
53% | With sodium hydroxide In methanol | A mixture of methyl 2-chloro-6-methyl-pyridine-4-carboxylate (1.8 g, 10 mmol) and 10percent palladium-on-charcoal catalyst (200 mg) in methanol (100 ml) was stirred under hydrogen at 5 atmospheres pressure. The catalyst was removed by filtration and the volatiles removed from the filtrate by evaporation. The residue was treated with 10percent aqueous sodium hydroxide solution and extracted with ether (3*30 ml). The combined extracts were dried (MgSO4) and the solvent removed by evaporation to give methyl 2-methyl-pyridine-4-carboxylate (800 mg, 53percent) as an oil. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
2 g | at -5 - 20℃; for 24 h; Inert atmosphere | General procedure: To a stirred solution of POCl3 (10 mL, 107 mmol) was added acid 2 (2.37 g, 15.5 mmol), and the resulting solution was heated to reflux for 18 h. The excess POCl3 was removed under reduced pressure, the residue was cooled to -5°C, methanol (20 mL) was added drop wise, and the resulting mixture was stirred for 24 h at rt. Distilled off MeOH completely, neutralized with solid NaHCO3, and partitioned between H2O (30 mL) and EtOAc (30 mL). The aqueous layer was extracted with EtOAc, dried (Na2SO4), and the solvent was removed under reduced pressure. The crude product was purified by flash chromatography over silica gel (CH2Cl2), to give ester 3a (2 g, 10.8 mmol, 69percent yield) as a white solid. Rf (Silica gel, CH2Cl2): 0.66; 1H NMR (300 MHz, CDCl3) δ 2.59 (s, 3H), 3.94 (s, 3H), 7.61(s, 1H), 7.67 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 24.2, 52.9, 120.8, 121.2, 140.3, 151.4, 160.5, 164.6; MS (EI, 70ev): m/z (percent) [M+H]+. 186 (100). |
[ 137129-98-7 ]
6-Chloro-2-methylnicotinic acid
Similarity: 0.90
[ 211915-96-7 ]
Methyl 5-amino-6-chloronicotinate
Similarity: 0.85
[ 849996-80-1 ]
2-Chloroquinoline-6-carboxylic acid
Similarity: 0.84
[ 295349-62-1 ]
tert-Butyl 2-chloroisonicotinate
Similarity: 0.82
[ 211915-96-7 ]
Methyl 5-amino-6-chloronicotinate
Similarity: 0.85
[ 295349-62-1 ]
tert-Butyl 2-chloroisonicotinate
Similarity: 0.82
[ 1196073-28-5 ]
Methyl 4,6-dichloro-2-methylnicotinate
Similarity: 0.82
[ 137129-98-7 ]
6-Chloro-2-methylnicotinic acid
Similarity: 0.90
[ 211915-96-7 ]
Methyl 5-amino-6-chloronicotinate
Similarity: 0.85
[ 295349-62-1 ]
tert-Butyl 2-chloroisonicotinate
Similarity: 0.82